Literature DB >> 34159661

COVID-19: Histopathological correlates of imaging patterns on chest computed tomography.

Azar Kianzad1, Lilian J Meijboom2, Esther J Nossent1, Eva Roos3, Bernadette Schurink3, Peter I Bonta4, Inge A H van den Berk5, Rieneke Britstra3, Jaap Stoker2, Anton Vonk Noordegraaf1, Paul van der Valk3, Erik Thunnissen3, Marianna Bugiani3, Harm Jan Bogaard1, Teodora Radonic3.   

Abstract

BACKGROUND AND
OBJECTIVE: Patients with coronavirus disease 2019 (COVID-19) pneumonia present with typical findings on chest computed tomography (CT), but the underlying histopathological patterns are unknown. Through direct regional correlation of imaging findings to histopathological patterns, this study aimed to explain typical COVID-19 CT patterns at tissue level.
METHODS: Eight autopsy cases were prospectively selected of patients with PCR-proven COVID-19 pneumonia with varying clinical manifestations and causes of death. All had been subjected to chest CT imaging 24-72 h prior to death. Twenty-seven lung areas with typical COVID-19 patterns and two radiologically unaffected pulmonary areas were correlated to histopathological findings in the same lung regions.
RESULTS: Two dominant radiological patterns were observed: ground-glass opacity (GGO) (n = 11) and consolidation (n = 16). In seven of 11 sampled areas of GGO, diffuse alveolar damage (DAD) was observed. In four areas of GGO, the histological pattern was vascular damage and thrombosis, with (n = 2) or without DAD (n = 2). DAD was also observed in five of 16 samples derived from areas of radiological consolidation. Seven areas of consolidation were based on a combination of DAD, vascular damage and thrombosis. In four areas of consolidation, bronchopneumonia was found. Unexpectedly, in samples from radiologically unaffected lung parenchyma, evidence was found of vascular damage and thrombosis.
CONCLUSION: In COVID-19, radiological findings of GGO and consolidation are mostly explained by DAD or a combination of DAD and vascular damage plus thrombosis. However, the different typical CT patterns in COVID-19 are not related to specific histopathological patterns. Microvascular damage and thrombosis are even encountered in the radiologically normal lung.
© 2021 The Authors. Respirology published by John Wiley & Sons Australia, Ltd on behalf of Asian Pacific Society of Respirology.

Entities:  

Keywords:  COVID-19; SARS-CoV-2, viral infection; acute respiratory distress syndrome; chest CT; coronavirus disease; histopathological and imaging

Year:  2021        PMID: 34159661     DOI: 10.1111/resp.14101

Source DB:  PubMed          Journal:  Respirology        ISSN: 1323-7799            Impact factor:   6.424


  4 in total

1.  Investigation of the relationship of CO-RADS and CT patterns with laboratory parameters in COVID-19 patients and a new perspective on the total CT scoring system.

Authors:  Nevin Aydin; Pinar Yildiz; Döndü Üsküdar Cansu; Elif Gündogdu; Rüya Mutluay; Göknur Yorulmaz; Melisa Sahin Tekin; Evin Kocaturk; I Özkan Alatas; Elif Doyuk Kartal; Nurettin Erben; Gül Durmaz; Nilgun Kasifoglu; Tercan Us; Garip Sahin; Cengiz Bal; Senay Yilmaz; Cengiz Korkmaz
Journal:  BMC Med Imaging       Date:  2022-07-20       Impact factor: 2.795

Review 2.  What Is COVID 19 Teaching Us about Pulmonary Ultrasound?

Authors:  Gino Soldati; Marcello Demi
Journal:  Diagnostics (Basel)       Date:  2022-03-29

3.  Respiratory symptoms and radiological findings in post-acute COVID-19 syndrome.

Authors:  Etienne-Marie Jutant; Olivier Meyrignac; Antoine Beurnier; Xavier Jaïs; Tai Pham; Luc Morin; Athénaïs Boucly; Sophie Bulifon; Samy Figueiredo; Anatole Harrois; Mitja Jevnikar; Nicolas Noël; Jérémie Pichon; Anne Roche; Andrei Seferian; Samer Soliman; Jacques Duranteau; Laurent Becquemont; Xavier Monnet; Olivier Sitbon; Marie-France Bellin; Marc Humbert; Laurent Savale; David Montani
Journal:  ERJ Open Res       Date:  2022-04-19

Review 4.  Contemporary Concise Review 2021: COVID-19 and other respiratory infections.

Authors:  Ken K P Chan; David S C Hui
Journal:  Respirology       Date:  2022-06-07       Impact factor: 6.175

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.